Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sapanisertib vs. Pazopanib in Advanced Sarcoma
NCT02601209Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Nov 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sapanisertib in sarcoma, sponsored by National Cancer Institute. Started Nov 2015; status: terminated.
02
Drugs
sapanisertib
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT02601209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02601209.